IP Library Granted Patent US 7,942,915
Granted Patent B2
US 7,942,915 · App. 11/598,412 · Granted May 17, 2011

Phototreatment device for use with coolants

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,942,915
App. No.
11/598,412
Granted
May 17, 2011
Kind
B2
Abstract

Methods and systems are disclosed for phototreatment in which replaceable containers comprising one or more adjuvant (consumable or re-useable) substances are employed. The adjuvant substance can be, for example, a topical substance or a coolant. Systems are disclosed for using a topical substance to detect contact of a phototreatment device with a tissue, detect speed of a phototreatment device over the tissue, detect regions of tissue that have been treated by a phototreatment device and/or to provide other benefits to the tissue such as improved skin tone and texture, tanning, etc. Safety systems are also disclosed that ensure that a proper consumable substance and/or container is connected to a phototreatment device and/or directed to a proper target. Additionally, cooling systems and methods that utilize phase change materials for extracting heat from a light generating device are disclosed.

Claims (39)

1. A system for operating a phototreatment device, the system comprising:

a topical substance for application to a region of a tissue, the topical substance has at least one parameter, wherein detection of a value of the parameter associated with the topical substance enables operation of a phototreatment device,

wherein operation of the phototreatment device is disabled until said value of the parameter is detected.

2. The system of claim 1 , wherein the topical substance comprises an eye irritant.

3. A system for operating a phototreatment device, the system comprising:

a marker for application to a region of a tissue, wherein detection of the marker enables operation of a function of a phototreatment device when detected by the device,

wherein the function of the phototreatment device is disabled when the marker is not detected.

4. The system of claim 3 , wherein the function of the phototreatment device is disabled until the marker is detected.

5. The system of claim 3 , wherein the marker is one of an absorptive marker, a fluorescent marker, an electric marker, an acoustic marker and a magnetic marker.

6. The system of claim 3 , wherein the marker comprises at least one of Food Blue, Toluidine Blue, Brilliant Green, Indigo Carmine, Fast Green, Erioglaucine, Methylene Blue, and Indocyanine Green; carbon particles; china ink; Cu ions, Fe ions, Au ions, Ag ions, and Zn ions, Eosin Y; D&C Orange Nos. 5, 10, and 11; D&C Red Nos. 21, 22, 27, and 28; Zinc sulfide, ALOE-STAT® CONDUCTIVE SKIN LOTION, LECTRON 2 CONDUCTIVITY GEL, ELECTRO-MIST ELECTROLYTE SPRAY, 3M CONDUCTIVE ELECTRODE GEL, FeO, CrO2, and magnetite.

7. A system for operating a phototreatment device, the system comprising:

a marker for application to a region of a tissue, wherein detection of the marker enables operation of a function of a phototreatment device when detected by the device,

wherein the marker comprises an eye irritant.

8. The system of claim 1 , wherein operation of the phototreatment device is disabled when the value of the parameter is not detected.

9. The system of claim 1 , wherein the detection of said value of the parameter activates a radiation source of the phototreatment device so as to enable operation of the device.

10. The system of claim 1 , wherein detection of said value of the parameter indicates whether the topical substance is on tissue.

11. The system of claim 1 , wherein said topical substance can be detected using optical, magnetic, electrical, or acoustic detection techniques.

12. The system of claim 1 , wherein said topical substance is characterized by an optical absorption spectrum substantially different from that of the skin.

13. The system of claim 1 , wherein said topical substance has an absorption spectrum outside a working spectrum of the phototreatment device.

14. The system of claim 1 , wherein the topical substance comprises a lotion.

15. The system of claim 1 , wherein the topical substance comprises a gel.

16. The system of claim 1 , wherein the topical substance comprises a cream.

17. The system of claim 1 , wherein the topical substance comprises at least one of water, alcohols, oils, powders, aerosols, granular particles, waxes, and films.

18. The system of claim 3 , wherein the marker is within a topical substance.

19. A system for operating a phototreatment device, the system comprising:

a marker for application to a region of a tissue, wherein detection of the marker enables operation of a function of a phototreatment device when detected by the device,

wherein the marker is within a topical substance and the topical substance comprises a lotion.

20. A system for operating a phototreatment device, the system comprising:

a marker for application to a region of a tissue, wherein detection of the marker enables operation of a function of a phototreatment device when detected by the device,

wherein the marker is within a topical substance and the topical substance comprises a gel.

21. A system for operating a phototreatment device, the system comprising:

a marker for application to a region of a tissue, wherein detection of the marker enables operation of a function of a phototreatment device when detected by the device,

wherein the marker is within a topical substance and the topical substance comprises a cream.

22. A system for operating a phototreatment device, the system comprising:

a marker for application to a region of a tissue, wherein detection of the marker enables operation of a function of a phototreatment device when detected by the device,

wherein the marker is within a topical substance and the topical substance comprises at least one of water, alcohols, oils, powders, aerosols, granular particles, waxes, and films.

23. A system for operating a phototreatment device, the system comprising:

a marker for application to a region of a tissue, wherein detection of the marker enables operation of a function of a phototreatment device when detected by the device,

wherein the marker is within a topical substance and the topical substance comprises an eye irritant.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066723/0227 →
TERMINATION AND RELEASE OF PATENTS Recorded Feb 29, 2024
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066707/0957 →
ABL NOTICE AND CONFIRMATION OF GRANT OFSECURITY INTEREST IN PATENTS Recorded Jan 12, 2024
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 066222/0937 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2020
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051496/0579 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 30, 2019
From: BANK OF AMERICA, N.A.
To: CYNOSURE, LLC
Reel/Frame 051447/0536 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
PARTIAL RELEASE OF SECURITY INTEREST ASSIGNMENTS RECORDED AT REEL/FRAME 042261/0911 Recorded Oct 5, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 044127/0923 →
SECURITY INTEREST Recorded May 3, 2017
From: CYNOSURE, INC.; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042261/0911 →
MERGER Recorded Jan 8, 2014
From: PALOMAR MEDICAL TECHNOLOGIES, INC.
To: PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 031936/0704 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2006
From: ALTSHULER, GREGORY B.; YAROSLAVSKY, ILYA; BURKE III, JAMES; EROFEEV, ANDREI V.; ZENZIE, HENRY; LOPEZ, ROBERT R.; GAAL, CHRISTOPHER
To: PALOMAR MEDICAL TECHNOLOGIES, INC.
Reel/Frame 018601/0320 →